Journal of Korean Neurosurgical Society

The Korean Neurosurgical Society (대한신경외과학회)
권호 표지
DOI QR코드

DOI QR Code

Clinical Course and Results of Surgery for Chronic Subdural Hematomas in Patients on Drugs Affecting Hemostasis

  • Received : 2015.12.16
  • Accepted : 2016.07.28
  • Published : 2017.03.01
Download PDF
⟨ Previous Next ⟩

Abstract

Objective : An apparent increase of use of drugs affecting hemostasis in our neurosurgical department since the 1990s has encouraged us to investigate whether these drugs influence the clinical course and results of surgery for chronic subdural hematoma (CSDH). Methods : This retrospective analysis included 178 patients admitted for CSDH from 2007 to 2011 who were divided into two groups : on drugs affecting hemostasis (40; 22%) and no bleeding disorders (138; 78%). Medications in the first group included oral anticoagulants (33; 82.5%), antiplatelets (5; 12.5%) and low molecular weight heparins (2; 5%). Results : The patients on drugs affecting hemostasis were older ($74.3{\pm}7.4$ vs. $68.4{\pm}14.8$; p-value 0.01) and the group without bleeding disorders had more head trauma history (61% vs. 38%, p-value 0.01). The groups did not differ in bilateral hematoma rates (25% vs. 20%, p-value=NS). At diagnosis, mean hematoma thickness was lower in patients on drugs affecting hemostasis ($18.7{\pm}7.4mm$ vs. $21.9{\pm}7.9mm$, p-value<0.01). Average stay of hospital was 1 day longer in patients on drugs affecting hemostasis ($11.7{\pm}4.1$ vs.$10.9{\pm}5.3$, p-value=NS) and was related to the necessity of bleeding disorder reversal. Mean neurological status at presentation was similar between the groups (p-value=NS) as was the likelihood of hematoma recurrence (p-value=NS). Glasgow Outcome Scale results were comparable. Conclusion : Patients on drugs affecting hemostasis are less often aware of a head trauma history, possibly suggesting a higher CSDH risk after minor trauma in this group. In these patients, smaller hematomas are symptomatic, probably due to faster hematoma formation. Drugs affecting hemostasis do not affect treatment results.

Keywords

References

  1. Aspegren OP, Astrand R, Lundgren MI, Romner B : Anticoagulation therapy a risk factor for the development of chronic subdural hematoma. Clin Neurol Neurosurg 115 : 981-984, 2013 https://doi.org/10.1016/j.clineuro.2012.10.008
  2. Baechli H, Nordmann A, Bucher HC, Gratzl O : Demographics and prevalent risk factors of chronic subdural haematoma : results of a large single-center cohort study. Neurosurg Rev 27 : 263-266, 2004
  3. Bret P, Lecuire J, Lapras C, Deruty R, Desgeorges M, Prudhon JL : Subdural hematoma and anticoagulant therapy. Neurochirurgie 22 : 603-620, 1976
  4. Campbell PG, Sen A, Yadla S, Jabbour P, Jallo J : Emergency reversal of antiplatelet agents in patients presenting with an intracranial hemorrhage : a clinical review. World Neurosurg 74 : 279-285, 2010 https://doi.org/10.1016/j.wneu.2010.05.030
  5. Forster MT, Mathe AK, Senft C, Scharrer I, Seifert V, Gerlach R : The influence of preoperative anticoagulation on outcome and quality of life after surgical treatment of chronic subdural hematoma. J Clin Neurosci 17 : 975-979, 2010 https://doi.org/10.1016/j.jocn.2009.11.023
  6. Gelabert-Gonzalez M, Iglesias-Pais M, Garcia-Allut A, Martinez-Rumbo R : Chronic subdural haematoma : surgical treatment and outcome in 1000 cases. Clin Neurol Neurosurg 107 : 223-229, 2005 https://doi.org/10.1016/j.clineuro.2004.09.015
  7. Grant FC : Chronic subdural haematoma. Ann Surg 86 : 485-493, 1927 https://doi.org/10.1097/00000658-192710000-00003
  8. Grines CL, Bonow RO, Casey DE Jr, Gardner TJ, Lockhart PB, Moliterno DJ, et al. : Prevention of premature discontinuation of dual antiplatelet therapy in patients with coronary artery stents : a science advisory from the american heart association, american college of cardiology, society for cardiovascular angiography and interventions, american college of surgeons, and american dental association, with representation from the american college of physicians. Circulation 115 : 813-818, 2007 https://doi.org/10.1161/CIRCULATIONAHA.106.180944
  9. Hamasaki T, Yamada K, Kuratsu J : Seizures as a presenting symptom in neurosurgical patients : a retrospective single-institution analysis. Clin Neurol Neurosurg 115 : 2336-2340, 2013 https://doi.org/10.1016/j.clineuro.2013.08.016
  10. Han HJ, Park CW, Kim EY, Yoo CJ, Kim YB, Kim WK : One vs. two burr hole craniostomy in surgical treatment of chronic subdural hematoma. J Korean Neurosurg Soc 46 : 87-92, 2009 https://doi.org/10.3340/jkns.2009.46.2.87
  11. Janowski M, Kunert P : Intravenous fluid administration may improve post-operative course of patients with chronic subdural hematoma : a retrospective study. PLoS One 7 : e35634, 2012 https://doi.org/10.1371/journal.pone.0035634
  12. Kageyama H, Toyooka T, Tsuzuki N, Oka K : Nonsurgical treatment of chronic subdural hematoma with tranexamic acid. J Neurosurg 119 : 332-337, 2013 https://doi.org/10.3171/2013.3.JNS122162
  13. Kanat A, Kayaci S, Yazar U, Kazdal H, Terzi Y : Chronic subdural hematoma in adults : why does it occur more often in males than females? Influence of patient's sexual gender on occurrence. J Neurosurg Sci 54 : 99-103, 2010
  14. Kim BG, Lee KS, Shim JJ, Yoon SM, Doh JW, Bae HG : What determines the laterality of the chronic subdural hematoma? J Korean Neurosurg Soc 47 : 424-427, 2010 https://doi.org/10.3340/jkns.2010.47.6.424
  15. Kunert P, Koszewski W : At the end of the 20th century those patients accounted only for 1.2% of all patients with CSDH in our Department.
  16. Lindvall P, Koskinen LO : Anticoagulants and antiplatelet agents and the risk of development and recurrence of chronic subdural haematomas. J Clin Neurosci 16 : 1287-1290, 2009 https://doi.org/10.1016/j.jocn.2009.01.001
  17. Miranda LB, Braxton E, Hobbs J, Quigley MR : Chronic subdural hematoma in the elderly : not a benign disease. J Neurosurg 114 : 72-76, 2011 https://doi.org/10.3171/2010.8.JNS10298
  18. Sambasivan M : An overview of chronic subdural hematoma : experience with 2300 cases. Surg Neurol 47 : 418-422, 1997 https://doi.org/10.1016/S0090-3019(97)00188-2
  19. Sim YW, Min KS, Lee MS, Kim YG, Kim DH : Recent changes in risk factors of chronic subdural hematoma. J Korean Neurosurg Soc 52 : 234-239, 2012 https://doi.org/10.3340/jkns.2012.52.3.234
  20. Slotty PJ, Kamp MA, Steiger SH, Cornelius JF, Macht S, Stummer W, et al. : Cerebral perfusion changes in chronic subdural hematoma. J Neurotrauma 30 : 347-351, 2013 https://doi.org/10.1089/neu.2012.2644
  21. Tahsim-Oglou Y, Beseoglu K, Hanggi D, Stummer W, Steiger HJ : Factors predicting recurrence of chronic subdural haematoma : the influence of intraoperative irrigation and low-molecular-weight heparin thromboprophylaxis. Acta Neurochir (Wien) 154 : 1063-1067; discussion 1068, 2012 https://doi.org/10.1007/s00701-012-1334-0
  22. Wada M, Yamakami I, Higuchi Y, Tanaka M, Suda S, Ono J, et al. : Influence of antiplatelet therapy on postoperative recurrence of chronic subdural hematoma : a multicenter retrospective study in 719 patients. Clin Neurol Neurosurg 120 : 49-54, 2014 https://doi.org/10.1016/j.clineuro.2014.02.007
  23. Weir B : Oncotic pressure of subdural fluids. J Neurosurg 53 : 512-515, 1980 https://doi.org/10.3171/jns.1980.53.4.0512
  24. White RH, McKittrick T, Hutchinson R, Twitchell J : Temporary discontinuation of warfarin therapy : changes in the international normalized ratio. Ann Intern Med 122 : 40-42, 1995 https://doi.org/10.7326/0003-4819-122-1-199501010-00006
  25. Yamashima T, Friede RL : Why do bridging veins rupture into the virtual subdural space? J Neurol Neurosurg Psychiatry 47 : 121-127, 1984 https://doi.org/10.1136/jnnp.47.2.121
  26. Yates S, Sarode R : Reversal of anticoagulant effects in patients with intracerebral hemorrhage. Curr Neurol Neurosci Rep 15 : 504, 2015 https://doi.org/10.1007/s11910-014-0504-2